ライフサイエンスコーパス: multi-drug resistance

1 o global health, made worse by the spread of multi-drug resistance.

2 ii is an important human pathogen due to its multi-drug resistance.

3 metabolism, stress responses, virulence and multi-drug resistance.

4 major contributor to the spread of bacterial multi-drug resistance.

5 tions in topoII have been linked to atypical multi-drug resistance.

6 tant diseases, including cystic fibrosis and multi-drug resistance.

7 ensis sp. nov., is noteworthy for exhibiting multi-drug resistance.

8 including in particular spatial evolution of multi-drug resistance.

9 largely responsible for the proliferation of multi-drug resistance.

10 nization, high level of transmissibility and multi-drug resistance.

11 ibodies or preventing microbes from evolving multi-drug resistance.

12 report that expression of an exogenous human multi-drug resistance 1 (MDR1) gene enables dramatic ex

13 mplex class I (MHC-I) expression, suppressed multi-drug resistance 1 (MDR1) induction and survival ge

14 , COMT (Catechol-O-Methyltransferase), MDR1 (multi-drug resistance 1), BDNF (brain derived neurotroph

15 genes such as CYP (cytochrome)3A4 and MDR-1 (multi-drug resistance-1), that are involved in this proc

16 bacteria increased colon inflammation in the multi-drug resistance 1a-deficient (Mdr1a (-/-) ) mouse

17 ne silencing on the plasmid RK2, a source of multi-drug resistance across diverse Gram-negative bacte

18 of DHM, which induces apoptosis and reverses multi-drug resistance against ovarian cancer cells throu

19 Here, we report direct evidence of multi-drug resistance among foals treated with MaR.

20 ydrophobic compounds have important roles in multi-drug resistance and can cause a number of diseases

21 Horizontal transfer of mobile DNA conferring multi-drug resistance and expression of a new superantig

22 formulate and analyse a stochastic model for multi-drug resistance and investigate the dependence of

23 Lowering multi-drug resistance and involving influx transportatio

24 rculosis Beijing genotype is associated with multi-drug resistance and is emerging.

25 ld more likely to harbour genes encoding for multi-drug resistance and yersiniabactin production comp

26 . cruzi, demonstrate that this can result in multi-drug resistance, and indicate that vigilance will

27 xplaining the elevated rates of triazole and multi-drug resistance associated with C. glabrata.

28 ths due to bacteria and reduce the spread of multi-drug-resistance, but cannot be regularly performed

29 om 40 to 23% (aPR: 0.48; 95% CI 0.32, 0.73). Multi-drug resistance declined from 86 to 70% (aPR: 0.32

30 de the development of asymptomatic shedding, multi-drug resistance during prolonged antiviral therapy

31 and we found evidence of the persistence of multi-drug resistance following export from East Asia.

32 s is associated with increased expression of multi-drug resistance gene ABCB1 (MDR1), whereas MRD6 (<

33 ression of drug resistance proteins, such as multi-drug resistance gene-1 P-glycoprotein (MDR1) and m

34 n of the message of MDR1, a gene involved in multi-drug resistance in cancer cells.

35 eutic effect and deal with the occurrence of multi-drug resistance in cancer treatment.

36 a major role in both intrinsic and acquired multi-drug resistance in Gram-negative bacteria.

37 also applies to antibiotics that may lead to multi-drug resistance in pathogenic bacteria, aptamer-ba

38 Our results indicate that MaR use promotes multi-drug resistance in R. equi and commensals that are

39 djuvant in cancer therapeutic, to combat the multi-drug resistance in solid tumors.

40 In a previous study, we discovered that multi-drug resistance is common in bacteria isolated fro

41 High prevalence of multi-drug-resistance makes it dangerous and difficult t

42 stem that uses MCSs to differentiate between multi drug resistance (MDR) and non-MDR cells does not y

43 tibiotic resistance remarkably rapidly, with multi drug-resistance (MDR) rates exceeding 60%.

44 and clinical isolates of P. aeruginosa with multi-drug resistance (MDR) both in vitro and in mouse m

45 We define a total risk measure for multi-drug resistance (MDR) by summing the area under th

46 Recovery of isolates with multi-drug resistance (MDR) genotypes was lower from McC

47 1) protease to develop mutations that confer multi-drug resistance (MDR) has been a major obstacle in

48 s of world, the extremely high prevalence of multi-drug resistance (MDR) in nematodes of sheep and go

49 Multi-drug resistance (MDR) is a phenomenon by which tum

50 The overall Multi-Drug Resistance (MDR) rate was 62.9%, with 33 (44.

51 n method, where the tested strains exhibited multi-drug resistance (MDR) to amoxicillin, cefotaxime,

52 es due to the lack of tumor-selectivity, the multi-drug resistance (MDR) to free chemotherapeutic dru

53 Multi-drug resistance (MDR) was present in 10% of P. aer

54 PA infections are challenging due to multi-drug resistance (MDR), biofilms, and/or antibiotic

55 In contrast, multi-drug resistance (MDR), resistance to traditional f

56 motherapy because of its tendency to develop multi-drug resistance (MDR), whose various underlying me

57 essful chemotherapy is intrinsic or acquired multi-drug resistance (MDR).

58 The human multi-drug resistance membrane transporter, P-glycoprote

59 Hypoxia contributes to multi-drug resistance, metastasis and cancer relapse thr

60 novel anti-virulence therapeutics to combat multi-drug resistance pathogenic strains.

61 onorrhoeae isolates with clinically relevant multi-drug resistance phenotypes in a murine vaginal gon

62 s like WhiB7, which account for the observed multi-drug resistance phenotypes.

63 l pfcrt alleles that could contribute to new multi-drug resistance phenotypes.

64 Due to multi-drug resistance, physicians increasingly use the l

65 oli O157:H7, as well as the broad host range multi-drug resistance plasmid pB10 from an unknown host.

66 new approaches to reduce the spread of these multi-drug-resistance plasmids.

67 scribed a macromolecular complex of GCC with multi-drug resistance protein 4 (MRP4), a cAMP/cGMP effl

68 e expression of the ABC transporter proteins multi-drug resistance protein-1 (MDR1, ABCB1, P-glycopro

69 otic polyspecific metabolite transporter and multi-drug resistance pumps.

70 observed the emergence of stable, low-level multi-drug resistance that was both time and concentrati

71 the processes of metastasis, development of multi-drug resistance, the 'Warburg effect', angiogenesi

72 acterium tuberculosis (Mtb), together called multi-drug resistance, threatens tuberculosis control.

73 at overexpression of Rac1 is associated with multi-drug resistance to the neoadjuvant chemotherapy (N

74 Kit and stably express P-glycoprotein (P-gp)/multi-drug resistance type 1 (MDR1).

75 target-specific ARGs to ARGs associated with multi-drug resistance was seen across influents and effl

76 Polyamine transport alterations and multi-drug resistance were eliminated as causes of the r

77 onstrate that the Bcl-2 oncoprotein produces multi-drug resistance when assessed in primary lymphomas

78 Because of increasing rates of multi-drug resistance within the KpSC, there is a growin